LONDON — Britain launched a public consultation Monday to ask whether controversial “three-parent” fertility treatments should be available to families hoping to avoid passing on incurable diseases.
The potential treatments, now only at research stage in laboratories in Britain and the United States, would involve implanting genetically modified embryos into women for the first time.
The techniques have become known as three-parent in vitro fertilization (IVF) because the offspring would have genes from a mother, a father and from a female donor.
They are designed to help families with mitochondrial diseases — incurable inherited conditions passed down the maternal line that affect around one in 6,500 children worldwide. Read full article.
